|
"tsai meen hsin"的相關文件
顯示項目 1-8 / 8 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-02-10T09:00:24Z |
Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma
|
Tseng, Jeng-Sen; Wang, Chih-Liang; Huang, Ming-Shyan; Chen, Chung-Yu; Chang, Cheng-Yu; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Wu, Chih-Wei; Yang, Cheng-Ta; Chen, Yuh-Min; Chang, Gee-Chen; MONG-HSUN TSAI |
| 臺大學術典藏 |
2020-02-10T09:00:24Z |
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemona?ve patients with EGFR-mutant lung adenocarcinoma
|
MONG-HSUN TSAI; Chang, Gee-Chen; Chen, Hsuan-Yu; Chen, Jeremy Jw; Su, Kang-Yi; Yu, Sung-Liang; Tsai, Meen-Hsin; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Yu, Chong-Jen; Liao, Wei-Yu; Tsai, Chi-Ren |
| 臺大學術典藏 |
2020-02-10T09:00:23Z |
Dynamic plasma EGFR mutation status as a predictor of EGFR-TKI efficacy in patients with EGFR-mutant lung adenocarcinoma
|
Tseng, Jeng-Sen; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Chen, Jeremy J. W.; Chang, Gee-Chen; MONG-HSUN TSAI |
| 臺大學術典藏 |
2018-09-10T14:49:40Z |
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma
|
Tseng, Jeng-Sen;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Yu, Chong-Jen;Liao, Wei-Yu;Tsai, Chi-Ren;Tsai, Meen-Hsin;Yu, Sung-Liang;Su, Kang-Yi;Chen, Jeremy J. W.;Chen, Hsuan-Yu;Chang, Gee-Chen; Tseng, J.-S. and Yang, T.-Y. and Chen, K.-C. and Hsu, K.-H. and Yu, C.-J. and Liao, W.-Y. and Tsai, C.-R. and Tsai, M.-H. and Yu, S.-L. and Su, K.-Y. and Chen, J.J.W. and Chen, H.-Y. and Chang, G.-C.; 俞松良;蘇剛毅;廖唯昱;余忠仁; SUNG-LIANG YU; Tseng, Jeng-Sen; Tseng, Jeng-Sen; CHONG-JEN YU; Yang, Tsung-Ying; Yang, Tsung-Ying; Chen, Kun-Chieh; WEI-YU LIAO; Hsu, Kuo-Hsuan; KANG-YI SU; Yu, Chong-Jen; Yu, Chong-Jen; Liao, Wei-Yu; Liao, Wei-Yu; Tsai, Chi-Ren; Tsai, Meen-Hsin; Yu, Sung-Liang; Yu, Sung-Liang; Su, Kang-Yi; Su, Kang-Yi; Chen, Jeremy J. W.; Chen, Jeremy J. W.; Chen, Hsuan-Yu; Chen, Hsuan-Yu; Chang, Gee-Chen |
| 國立臺灣大學 |
2015 |
Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma
|
Tseng, Jeng-Sen; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Chen, Jeremy J. W.; Chang, Gee-Chen; 俞松良; 蘇剛毅 |
| 臺北醫學大學 |
2014 |
Impact of EGFR Mutation Detection Methods on the Efficacy of Erlotinib in Patients with Advanced EGFR-Wild Type Lung Adenocarcinoma
|
Tseng, Jeng-Sen;Wang, Chih-Liang;Huang, Ming-Shyan;Chen, Chung-Yu;Chang, Cheng-Yu;Yang, Tsung-Ying;Tsai, Chi-Ren;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Tsai, Meen-Hsin;Yu, Sung-Liang;Su, Kang-Yi;Wu, Chih-Wei;Yang, Cheng-Ta;Chen, Yuh-Min;Chang, Gee-Chen |
| 國立臺灣大學 |
2014 |
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaive patients with EGFR-mutant lung adenocarcinoma
|
Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Yu, Chong-Jen; Liao, Wei-Yu; Tsai, Chi-Ren; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Chen, Jeremy J. W.; Chen, Hsuan-Yu; Chang, Gee-Chen; 俞松良; 蘇剛毅; 廖唯昱; 余忠仁 |
| 國立臺灣大學 |
2014 |
Impact of EGFR Mutation Detection Methods on the Efficacy of Erlotinib in Patients with Advanced EGFR-Wild Type Lung Adenocarcinoma
|
Tseng, Jeng-Sen; Wang, Chih-Liang; Huang, Ming-Shyan; Chen, Chung-Yu; Chang, Cheng-Yu; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Wu, Chih-Wei; Yang, Cheng-Ta; Chen, Yuh-Min; Chang, Gee-Chen; 俞松良; 蘇剛毅; 陳崇裕 |
顯示項目 1-8 / 8 (共1頁)
1
每頁顯示[10|25|50]項目
|
